Immunotherapy in Endometrial Cancer: Molecular Classification, Clinical Evidence, and Therapeutic Implications: A Narrative Review.

Padilla-Iserte P, Cabrera S, Gatius Calderó S, de Juan Ferré A, Majercakova K, Rubio-Pérez MJ, Romero I, Barretina-Ginesta MP, Orpinell MB

Open source

DOI
10.3390/cancers18111709
Published
2026 May 24
Container
Cancers
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers18111709,
  title = {Immunotherapy in Endometrial Cancer: Molecular Classification, Clinical Evidence, and Therapeutic Implications: A Narrative Review.},
  author = {Padilla-Iserte P and Cabrera S and Gatius Calderó S and de Juan Ferré A and Majercakova K and Rubio-Pérez MJ and Romero I and Barretina-Ginesta MP and Orpinell MB},
  year = {2026},
  journal = {Cancers},
  doi = {10.3390/cancers18111709},
  url = {https://doi.org/10.3390/cancers18111709}
}

RIS

TY  - JOUR
TI  - Immunotherapy in Endometrial Cancer: Molecular Classification, Clinical Evidence, and Therapeutic Implications: A Narrative Review.
AU  - Padilla-Iserte P
AU  - Cabrera S
AU  - Gatius Calderó S
AU  - de Juan Ferré A
AU  - Majercakova K
AU  - Rubio-Pérez MJ
AU  - Romero I
AU  - Barretina-Ginesta MP
AU  - Orpinell MB
PY  - 2026
JO  - Cancers
DO  - 10.3390/cancers18111709
UR  - https://doi.org/10.3390/cancers18111709
ER  - 

APA

P, P., S, C., S, G. C., A, D. J. F., K, M., MJ, R., I, R., MP, B., & MB, O. (2026). Immunotherapy in Endometrial Cancer: Molecular Classification, Clinical Evidence, and Therapeutic Implications: A Narrative Review.. Cancers. https://doi.org/10.3390/cancers18111709

Source records